The mammalian target of rapamycin (mTOR) is essential for skeletal myogenesis through controlling distinct cellular pathways. The importance of the canonical mTOR complex 1 signaling components, including raptor, S6K1, and Rheb, had been suggested in muscle maintenance, growth, and metabolism. However, the role of those components in myogenic differentiation is not entirely clear. In this study we have investigated the functions of raptor, S6K1, and Rheb in the differentiation of C2C12 mouse myoblasts. We find that although mTOR knockdown severely impairs myogenic differentiation as expected, the knockdown of raptor, as well as Rheb, enhances differentiation. Consistent with a negative role for these proteins in myogenesis, overexpression of raptor or Rheb inhibits C2C12 differentiation. On the other hand, neither knockdown nor overexpression of S6K1 has any effect. Moreover, the enhanced differentiation elicited by raptor or Rheb knockdown is accompanied by increased Akt activation, elevated IRS1 protein levels, and decreased Ser-307 (human Ser-312) phosphorylation on IRS1. Finally, IRS1 knockdown eliminated the enhancement in differentiation elicited by raptor or Rheb knockdown, suggesting that IRS1 is a critical mediator of the myogenic functions of raptor and Rheb. In conclusion, the Rheb-mTOR/raptor pathway negatively regulates myogenic differentiation by suppressing IRS1-PI3K-Akt signaling. These findings underscore the versatility of mTOR signaling in biological regulations and implicate the existence of novel mTOR complexes and/or signaling mechanism in skeletal myogenesis.During embryonic skeletal myogenesis, cells in somites commit to myogenic lineage and become myoblasts, which differentiate and fuse to form multinucleated myofibers (1). This is a highly coordinated process where various environmental cues and signaling pathways integrate to regulate the formation of skeletal muscle (2, 3). This process is largely recapitulated by the in vitro differentiation of myoblasts, such as the C2C12 mouse satellite cell line. Upon growth factor withdrawal, these cells produce insulin-like growth factor II (IGF-II), 2 which in an autocrine fashion stimulates myogenic differentiation (4). One of the critical pathways downstream of myogenic IGF signaling is the PI3K-Akt pathway (5, 6), and insulin receptor substrate 1 (IRS1) is a well-established mediator of IGF receptor activation of downstream signaling (7). mTOR, the mammalian target of rapamycin, has long been recognized as a nutrient-and energy-sensing signaling hub regulating a wide spectrum of cellular processes including proliferation, growth, survival, differentiation, and metabolism (8). It nucleates two distinct biochemical complexes: the raptor-associated mTORC1 is acutely sensitive to rapamycin, and it targets S6K1 and 4E-BP1 to regulate translation initiation, among other functions; the rictor-associated mTORC2 is a kinase for the multifunctional kinase Akt and it also regulates cytoskeleton reorganization (9). Although mTORC2 was initially characte...